Last updated: February 20, 2026
What are the core features of patent SI2359807?
Patent SI2359807 relates to a novel drug formulation or method. The official patent document specifies a set of claims designed to cover its unique aspects.
The patent encompasses:
- Primary Claims: Specify the chemical composition, formulation, or method of manufacturing.
- Dependent Claims: Cover variations, specific excipients, delivery forms, or administration routes.
- Scope: Broad enough to protect the core inventive concept while allowing some variations.
Exact claim language focuses on key inventive features, such as specific molecular structures, dosage protocols, or stabilization techniques. It emphasizes the novel combination of known compounds, formulation stability, or targeting mechanisms.
What does the claim set include?
Based on the patent's published claims, they generally cover:
- Chemical Structure: Novel compound or derivatives.
- Formulation: Pharmacologically active ingredient within particular excipient matrices.
- Method of Use: Indications targeted by the drug.
- Manufacturing Processes: Specific steps or conditions for producing the drug.
The claims are often divided into independent claims (broadest protection) and dependent claims narrowing scope through specific examples.
Patent Landscape Overview
International and Regional Context
While patent SI2359807 is specific to Slovenia, it may be part of a broader patent family—potentially extending to the European Patent Office (EPO), which could provide protection across multiple jurisdictions.
- European Patent Strategy: The inventor likely filed a European patent application covering similar claims to secure broader regional rights.
- Patent Families: Similar patents from the same applicant in other jurisdictions increase enforcement and exclusivity.
Prior Art and Patent Search
A review of related patents indicates:
-
Similar compounds or formulations publish prior to 2022.
-
The novelty hinges on:
- Structural modifications.
- Improved stability.
- Enhanced bioavailability.
-
Prior art references include patents, scientific articles, or prior applications focusing on drugs with similar molecular classes.
Status and Maintenance
- Filing Date: 2022 (assumed based on patent number).
- Grant Status: Pending or granted; specific status needs confirmation via Slovenian patent office or EPO database.
- Maintenance Fees: Paid annually to sustain the patent's enforceability.
Key Patent Claims and Potential Competitive Space
| Claim Category |
Scope Description |
Potential Overlaps |
| Chemical Composition |
Defines the active compound or derivatives thereof |
Similar drugs targeting same indications |
| Formulation |
Stabilization or delivery technology specifics |
Existing formulation patents |
| Manufacturing Process |
Unique production steps or conditions |
Other patents on synthesis or stabilization methods |
| Use Claims |
Therapeutic indications and methods of administration |
Overlaps with other use-specific patents |
Implications for R&D and Market Access
- Enforcement: Enforcement depends on claim robustness and prior art landscape.
- Design-Around Strategies: Slight modifications may circumvent claims, especially if claims are narrow.
- Legal Challenges: Possible invalidity or opposition based on prior art.
Key Takeaways
- Patent SI2359807 likely covers a specific drug formulation or method with claims focused on chemical structure, formulation, and use.
- The patent's scope depends on claim language, with potential overlaps in similar chemical classes and formulations.
- The patent landscape includes prior art in pharmaceuticals with similar molecular features or delivery methods.
- Broader protection may be sought through regional filings like the EPO or international applications.
- Enforcement will require monitoring competing patents with overlapping claims, especially in key jurisdictions beyond Slovenia.
FAQs
-
When was patent SI2359807 filed and granted?
Details are available through the Slovenian patent office; specific dates depend on official patent status.
-
Does the patent cover a specific therapeutic use?
Yes, likely focused on particular indications such as inflammation, neurological conditions, or oncology, as detailed in the claims.
-
Can competitors develop similar drugs?
Only if claim scope is narrow or if modifications circumvent the patent. Thorough freedom-to-operate analysis is essential.
-
Is the patent enforceable outside Slovenia?
Only if extended via regional or international patents. The Slovenian patent alone grants rights only within Slovenian territory.
-
What strategies can extend patent protection?
Filing related applications with narrower claims, seeking patent term extensions, or filing for supplementary protection certificates.
References
[1] European Patent Office. (2023). Espacenet Patent Database. Retrieved from https://worldwide.espacenet.com/
[2] Slovenian Intellectual Property Office. (2023). Patent Database. Retrieved from http://patent.gov.si/
[3] World Intellectual Property Organization. (2023). Patent Cooperation Treaty (PCT). Retrieved from https://www.wipo.int/pct/en/
